Have a feature idea you'd love to see implemented? Let us know!
Back to GILD overview

GILD Gilead Sciences PE ratio, current and historical analysis

As of Oct 29, 2024, the Gilead Sciences stock's PE ratio is 103.61. This results from the current EPS of $0.85 and stock price of $88.07. The P/E ratio has an increase of 39% from the past four quarters average of 74.4.

GILD PE ratio history

How has GILD's PE ratio performed in the past

The PE ratio of Gilead Sciences has averaged 45.49 over the last ten years. The current PE ratio of 103.61 is 128% above the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Dec 2020 quarter at 582.6, when the stock price was $58.26 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.

Average
45.49
Median
16.21
Minimum
7.1
Maximum
582.6

Gilead Sciences PE ratio by year

Maximum annual increase: 3,700.39% in 2020

Maximum annual decrease: -97.49% in 2021

Year PE ratio Change
2023 17.84 -23.96%
2022 23.46 60.25%
2021 14.64 -97.49%
2020 582.6 3,700.39%
2019 15.33 2.96%
2018 14.89 -26.43%
2017 20.24 185.07%
2016 7.1 -13.2%
2015 8.18 -31.03%
2014 11.86 -68.25%

GILD average PE ratio chart

What is the average PE ratio of GILD for the past years

The current PE ratio of GILD is greater than its 3, 5 and 10-year historical averages.

3-year avg
39.11
5-year avg
77.71
10-year avg
45.49
15-year avg
35.97

GILD PE vs peers

What is GILD's PE ratio compared to its peers

Compared to its peers LLY and QGEN, GILD's PE ratio stands lower, however it is higher than JNJ's and ABBV's. Gilead Sciences's PE ratio is trading above the peer group average of 37.19.

Stock name PE ratio Market cap
MRK Merck & Co Inc 19.21 $263.37B
BIIB Biogen Inc 22.8 $26.47B
JNJ Johnson & Johnson 26.62 $386.5B
AMGN Amgen Inc 53.93 $169.52B
ABBV AbbVie Inc 66.21 $350.85B
LLY ELI LILLY & Co 102.62 $794.92B
GILD Gilead Sciences Inc 103.71 $109.75B
QGEN Qiagen NV 151.07 $9.47B
VRTX Vertex Pharmaceuticals Inc N/A $122.44B
ILMN Illumina Inc N/A $23.43B
PFE Pfizer Inc N/A $160.31B

Frequently asked questions

What is Gilead Sciences's PE ratio?

GILD stock has a price to earnings ratio of 103.61 as of Oct 29, 2024.

What is the 3-year average PE ratio for Gilead Sciences (GILD)?

Over the last 3 years, the average price to earnings ratio for GILD stock is 39.11.

What is the 5-year average PE ratio for Gilead Sciences (GILD)?

Over the last 5 years, the average price to earnings ratio for GILD stock is 77.71.

What is the highest PE ratio for GILD?

In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 582.6.

How does the current PE ratio for GILD compare to its historical average?

GILD's price to earnings ratio is currently 128% above its 10-year historical average.

Why is Gilead Sciences's PE ratio so high?

A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.

How is GILD's PE ratio calculated (Gilead Sciences PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 29, 2024), Gilead Sciences's stock price is $88.07. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.85. Therefore, Gilead Sciences's P/E ratio for today is 103.61. PE RATIO(103.61) = STOCK PRICE($88.07) / TTM EPS($0.85)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.